ARUP Laboratories

Data from the 2022 Client Satisfaction Survey shows that an overwhelming majority of our clients view ARUP favorably and would recommend ARUP to colleagues.

Drawing on ARUP experts' extensive knowledge about the diagnosis and treatment of cerebral creatine deficiency syndromes, a new initiative seeks answers for those with creatine transporter deficiency.

Rong Mao, MD, FACMG, looks forward to bridging the gap between laboratory and clinical practice after her recent election to the ACMGF board of directors, and will present at the ACMG meeting.